Literature DB >> 3512508

Beta-lactam antibiotics.

G N Rolinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3512508     DOI： 10.1093/jac/17.1.5

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  12 in total

1.  Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids.

Authors:  M M Ochs; M P McCusker; M Bains; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Antibacterial therapy for acute group a streptococcal pharyngotonsillitis: short-course versus traditional 10-day oral regimens.

Authors:  Itzhak Brook
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 3.  Bacterial challenges and evolving antibacterial drug strategy.

Authors:  B Watt; J G Collee
Journal:  Postgrad Med J       Date:  1992-01       Impact factor: 2.401

4.  In vitro activity of aztreonam, cefotaxime, ceftazidime and imipenem combined with ciprofloxacin against gram-negative bacilli and compared with amikacin combinations against Pseudomonas aeruginosa.

Authors:  M Díez Enciso
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

5.  Therapeutic effects of cefpirome (HR 810) on experimental mixed infections with Enterococcus faecalis and Escherichia coli in mice.

Authors:  S Arai; S Hayashi
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

6.  Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients.

Authors:  C S Verhagen; B de Pauw; T de Witte; J Janssen; K Williams; P de Mulder; T Bothof
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

7.  In vitro activity of cefotaxime against clinically significant pathogens.

Authors:  S Nakashio; M Nakamura
Journal:  Drugs       Date:  1988       Impact factor: 9.546

8.  Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients.

Authors:  C Verhagen; B E De Pauw; K J Williams; W Du Bois
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

9.  Highly conformationally constrained halogenated 6-spiroepoxypenicillins as probes for the bioactive side-chain conformation of benzylpenicillin.

Authors:  R E Shute; D E Jackson; B W Bycroft
Journal:  J Comput Aided Mol Des       Date:  1989-06       Impact factor: 3.686

10.  Cefepime : The Last Generation or the First Enhanced-Potency Broad Spectrum Cephalosporin?

Authors:  C C Sanders; E S Moland
Journal:  Clin Drug Investig       Date:  1995-12       Impact factor: 2.859
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.